Fictional caregiver talking to her fictional patient in a bright consultation room about KISQALI® for breast cancerLogo of KISQALI

For Healthcare
Professionnals
Outside the US

In EBC & ABC
NO NEWS IS
GOOD NEWS

Welcome !

KISQALI is proven in patients with HR+/HER2 - early and advanced breast cancer (EBC and ABC).
To find out more, start by choosing an indication.